A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide.

MLA

Cerchione, Claudio, et al. “A Case of Efficacy of Bendamustine in Heavily Pretreated Multiple Myeloma, Refractory to Pomalidomide.” Clinical Case Reports, vol. 5, no. 4, Mar. 2017, pp. 505–07. EBSCOhost, https://doi.org/10.1002/ccr3.773.

APA

Cerchione, C., Nappi, D., Di Perna, M., Zacheo, I., Migliaccio, I., Salvatore, D., Picardi, M., Pane, F., & Catalano, L. (2017). A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide. Clinical Case Reports, 5(4), 505–507. https://doi.org/10.1002/ccr3.773

Chicago

Cerchione, Claudio, Davide Nappi, Maria Di Perna, Irene Zacheo, Ilaria Migliaccio, Dalila Salvatore, Marco Picardi, Fabrizio Pane, and Lucio Catalano. 2017. “A Case of Efficacy of Bendamustine in Heavily Pretreated Multiple Myeloma, Refractory to Pomalidomide.” Clinical Case Reports 5 (4): 505–7. doi:10.1002/ccr3.773.